Company
Cellares
Accelerating Access to Life-Saving Therapies
Also known as Cellares Corporation
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Cellares Corporation
- cellares.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Meet Total Patient Demand by Delivering Cell Therapy Manufacturing Excellence At Scale Across a Global Network of IDMO Smart Factories
Funding snapshot
- Total raised
- $584MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series D+, $50M2026-06-15
Funding rounds
- Series D+
- $50M2026-06-15, Company stated
- Series D+
- $277M2026-06-09, Company stated
- Series D+
- $257M2026-01-28, Company stated
- Round, 2021
- $82M2021-04-12, SEC form D sold, 9 investors
Products
- Hardware
- Cell Q
- Hardware
- Cell Shuttle
Loading relationship preview